Jaejin An to United States
This is a "connection" page, showing publications Jaejin An has written about United States.
Connection Strength
0.727
-
Development and Validation of an Incident Hypertension Risk Prediction Model for Young Adults. J Am Heart Assoc. 2025 Jul 15; 14(14):e040769.
Score: 0.132
-
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction. J Am Heart Assoc. 2025 Feb 18; 14(4):e039454.
Score: 0.128
-
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems. Clin J Am Soc Nephrol. 2022 10; 17(10):1457-1466.
Score: 0.108
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.096
-
Association between different types of comorbidity and disease burden in patients with diabetes. J Diabetes. 2019 Jan; 11(1):65-74.
Score: 0.081
-
Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States. Ophthalmic Epidemiol. 2018 06; 25(3):257-265.
Score: 0.078
-
Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res (Hoboken). 2016 05; 68(5):629-37.
Score: 0.070
-
GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. Alzheimers Dement. 2025 Sep; 21(9):e70621.
Score: 0.033